Benchmarking Codon Optimization Strategies for Improved Antibody Expression
Summary
This article/webinar promotion discusses how antibody expression titers are critical for screening efficiency, developability, and manufacturing economics in biopharma. It highlights that poor antibody expression often stems from underlying DNA sequences rather than just downstream processes. The piece promotes a GEN webinar featuring Ansa Biotechnologies and Axio BioPharma, focusing on AI-powered codon optimization strategies to improve transient antibody expression yield, and emphasizes the importance of controlled side-by-side benchmarking for evaluating DNA construct design choices.
Source
bskyBenchmarking Codon Optimization Strategies for Improved Antibody Expressionhubs.liKey quotes
· 3 pulledAntibody expression titers are key drivers of screening efficiency in discovery, developability, manufacturing economics, and development timelines.
Although it is possible to address poor antibody expression by increasing overall batch size and optimizing downstream processes, the root cause often lies in the underlying DNA sequences.
Controlled benchmarking studies are helpful for systematically evaluating DNA construct design decisions that impact titers.
You might also wanna read
AI-Driven Protein Binder Design: Progress and Pitfalls in Evaluation Practices
This article discusses the rapid advancement of de novo protein binder design using AI, including antibodies and nanobodies. While the field
boltz.bio·6d ago
BioTradingArena: AI Biotech Trading Benchmark with 655 Validated Catalyst Cases
BioTradingArena is a benchmark dataset for AI-driven biotech trading, containing 655 validated biotech catalyst cases with linked clinical t
biotradingarena.com·4mo ago
Alp Bio's AI platform predicts immune reactions to biologic drugs in early development
An interview with Christian Vahlensieck, co-founder of Alp Bio, a Swiss startup using an AI-powered platform combined with lab-grown human i
Alp Bio's AI platform predicts immune reactions to biologic drugs earlier in development
An interview with Christian Vahlensieck, co-founder of Alp Bio, a Swiss startup using an AI-powered platform combined with lab-grown human i
Investigation finds over 450 instances of apparent data manipulation in Thermo Fisher antibody catalog
An investigation by Sholto David reveals widespread apparent data manipulation in Thermo Fisher Scientific's antibody catalog. More than 450
reeserichardson.blog·26d ago
Extropic presents first pharmaceutical application for thermodynamic computing hardware with codon optimization
This paper from Extropic Corp. presents the first concrete pharmaceutical application mapped to thermodynamic hardware, focusing on energy-e
Comments
Sign in to join the conversation.
No comments yet. Be the first.